Mor is Peel’s VP of Technology and Early Development and the Managing Director of Peel Therapeutics Israel Ltd, overseeing the science and operations of the R&D site.
Mor was part of Peel from its early days in 2015 and founded the Israeli subsidiary in 2017.
Mor received her PhD in biotechnology and MBA with a StartUp focus from the Technion – Israel Institute of Technology.
As part of her scientific research, Mor authored 20 papers in the fields of biotechnology and drug delivery. She has multidisciplinary experience in biochemistry, molecular biology, protein engineering, biochemical analytics and drug delivery.
Mor is a wine lover and worked in the wine industry for many years, both in Israel and California.